# Akoya BioSciences Inc. (AKYA)

Source: https://www.quantisnow.com/company/AKYA
Generated: 2026-11-15T05:58:56.823Z

- Ticker: AKYA
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Laboratory Analytical Instruments
- IPO year: 2021
- Website: akoyabio.com

## About

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research. The company offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. It provides two distinct solutions, the CODEX and Phenoptics platforms, to serve the diverse needs of researchers across discovery, translational, and clinical research. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.

## Latest AKYA news and filings

- 2025-07-18 13:25 UTC [SEC Form 15-12G filed by Akoya BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-akoya-biosciences-inc-6125101)
- 2025-07-14 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Akoya BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-akoya-biosciences-inc-6118456)
- 2025-07-11 00:41 UTC [SEC Form 4] [Director Mendel Scott disposed of 28,500 shares, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-mendel-scott-disposed-of-28500-shares-closing-all-direct-6117334)
- 2025-07-11 00:40 UTC [SEC Form 4] [Chief Business Officer Ramachandran Niro Ph.D acquired 62,566 shares, covered exercise/tax liability with 42,148 shares and disposed of 282,555 shares, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-business-officer-ramachandran-niro-phd-acquired-62566-shares-covered-6117333)
- 2025-07-11 00:40 UTC [SEC Form 4] [President and CEO Mckelligon Brian disposed of 947,688 shares, acquired 724,428 shares and covered exercise/tax liability with 196,866 shares, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/president-and-ceo-mckelligon-brian-disposed-of-947688-shares-acquired-6117332)
- 2025-07-11 00:40 UTC [SEC Form 4] [Chief Legal Officer Kamocsay Jennifer disposed of 179,272 shares, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-legal-officer-kamocsay-jennifer-disposed-of-179272-shares-closing-6117331)
- 2025-07-11 00:39 UTC [SEC Form 4] [CFO Ek John Frederick disposed of 268,202 shares, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/cfo-ek-john-frederick-disposed-of-268202-shares-closing-all-6117329)
- 2025-07-11 00:39 UTC [SEC Form 4] [Chief Clinical Officer Bamford Pascal disposed of 205,738 shares, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-clinical-officer-bamford-pascal-disposed-of-205738-shares-closing-6117328)
- 2025-07-11 00:38 UTC [SEC Form 4] [Director Winkler Matthew disposed of 984,513 shares, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-winkler-matthew-disposed-of-984513-shares-closing-all-direct-6117326)
- 2025-07-11 00:38 UTC [SEC Form 4] [SEC Form 4 filed by Director Shepler Robert G](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-shepler-robert-g-6117325)
- 2025-07-11 00:38 UTC [SEC Form 4] [SEC Form 4 filed by Director Schnettler Thomas P](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-schnettler-thomas-p-6117324)
- 2025-07-11 00:37 UTC [SEC Form 4] [Director Raffin Thomas A. disposed of 17,909,839 shares (SEC Form 4)](https://www.quantisnow.com/insight/director-raffin-thomas-a-disposed-of-17909839-shares-sec-form-6117323)
- 2025-07-11 00:37 UTC [SEC Form 4] [Director Lai Goldman Myla disposed of 20,000 shares, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-lai-goldman-myla-disposed-of-20000-shares-closing-all-6117322)
- 2025-07-08 17:06 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Akoya BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-akoya-biosciences-inc-6114024)
- 2025-07-08 16:54 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Akoya BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-akoya-biosciences-inc-6114021)
- 2025-07-08 16:44 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Akoya BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-akoya-biosciences-inc-6114014)
- 2025-07-08 16:37 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Akoya BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-akoya-biosciences-inc-6114012)
- 2025-07-08 16:29 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Akoya BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-akoya-biosciences-inc-6114006)
- 2025-07-08 16:24 UTC [SEC Form POS AM filed by Akoya BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-akoya-biosciences-inc-6114005)
- 2025-07-08 14:54 UTC [SEC Form 25-NSE filed by Akoya BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-akoya-biosciences-inc-6113943)
- 2025-07-08 13:23 UTC [SEC Form 8-K] [Akoya BioSciences Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Changes in Control of Registrant, Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/akoya-biosciences-inc-filed-sec-form-8-k-termination-of-a-6113869)
- 2025-07-07 20:04 UTC [SEC Form 8-K] [Akoya BioSciences Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/akoya-biosciences-inc-filed-sec-form-8-k-submission-of-matters-6112618)
- 2025-06-16 15:03 UTC [SEC Form DEFM14A] [SEC Form DEFM14A filed by Akoya BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-defm14a-filed-by-akoya-biosciences-inc-6087549)
- 2025-06-04 20:01 UTC [SEC Form 425] [SEC Form 425 filed by Akoya BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-akoya-biosciences-inc-6072171)
- 2025-06-02 21:52 UTC [SEC Form 4] [Chief Clinical Officer Bamford Pascal covered exercise/tax liability with 670 shares, decreasing direct ownership by 0.32% to 205,738 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-clinical-officer-bamford-pascal-covered-exercisetax-liability-with-670-6068306)
- 2025-06-02 20:05 UTC [SEC Form 8-K] [Akoya BioSciences Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/akoya-biosciences-inc-filed-sec-form-8-k-other-events-6067419)
- 2025-05-23 18:21 UTC [Kent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative Proposal](https://www.quantisnow.com/insight/kent-lake-responds-to-quanterixs-post-effective-amendment-and-akoyas-superior-6056252)
- 2025-05-21 10:00 UTC [SEC Form 8-K] [Akoya BioSciences Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/akoya-biosciences-inc-filed-sec-form-8-k-other-events-6051448)
- 2025-05-12 23:43 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Akoya BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-akoya-biosciences-inc-6034374)
- 2025-05-12 20:11 UTC [SEC Form 425] [SEC Form 425 filed by Akoya BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-akoya-biosciences-inc-6033124)
- 2025-05-12 20:10 UTC [SEC Form 8-K] [Akoya BioSciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/akoya-biosciences-inc-filed-sec-form-8-k-results-of-operations-6033092)
- 2025-05-12 20:08 UTC [SEC Form 425] [SEC Form 425 filed by Akoya BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-akoya-biosciences-inc-6033054)
- 2025-05-12 20:05 UTC [Earnings] [Akoya Biosciences Reports First Quarter 2025 Financial Results](https://www.quantisnow.com/insight/akoya-biosciences-reports-first-quarter-2025-financial-results-6032820)
- 2025-04-30 21:12 UTC [Amendment: SEC Form SCHEDULE 13D/A filed by Akoya BioSciences Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13da-filed-by-akoya-biosciences-inc-6011290)
- 2025-04-30 20:40 UTC [Amendment: SEC Form SCHEDULE 13D/A filed by Akoya BioSciences Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13da-filed-by-akoya-biosciences-inc-6011026)
- 2025-04-30 12:00 UTC [Kent Lake Issues Statement on Quanterix's Blatant Disregard for Will of Shareholders](https://www.quantisnow.com/insight/kent-lake-issues-statement-on-quanterixs-blatant-disregard-for-will-6009019)
- 2025-04-29 21:17 UTC [SEC Form 425] [SEC Form 425 filed by Akoya BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-akoya-biosciences-inc-6008104)
- 2025-04-29 21:15 UTC [SEC Form 8-K] [Akoya BioSciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/akoya-biosciences-inc-filed-sec-form-8-k-entry-into-a-6008095)
- 2025-04-29 13:12 UTC [SEC Form 425] [SEC Form 425 filed by Akoya BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-akoya-biosciences-inc-6006458)
- 2025-04-29 11:00 UTC [Quanterix and Akoya Biosciences Announce Amended Merger Agreement](https://www.quantisnow.com/insight/quanterix-and-akoya-biosciences-announce-amended-merger-agreement-6005888)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/AKYA
- Earnings history: https://www.quantisnow.com/earnings/AKYA
- Dividend history: https://www.quantisnow.com/dividends/AKYA
- Insider transactions: https://www.quantisnow.com/insiders/AKYA
- Options chain: https://www.quantisnow.com/options/AKYA
- SEC 8-K filings only: https://www.quantisnow.com/company/AKYA/8-k
- RSS and alerts for AKYA: https://www.quantisnow.com/docs/rss-feeds.md